CBD oil in MCT (25%)

Natural THC-free broad-spectrum cannabidiol produced in Switzerland

Our CBD oil in MCT oil contains 25% broad-spectrum cannabidiol (2500 mg CBD), extracted from certified Swiss hemp. This THC-free formulation combines CBD with easily absorbed MCT oil, ideal for cosmetic skin care. The bottle comes with a medical pipette for easy and accurate dosing.

Benefits and effects

CBD oil dissolved in MCT provides the skin with natural fatty acids that are quickly absorbed and can help keep the skin balanced and moist. MCT oil is known for its medium-chain triglycerides that nourish the skin, while CBD can have soothing properties, making the oil particularly suitable for dry or sensitive skin. Note: This product is intended for cosmetic use only and not for ingestion.

Ingredients and contents

• Ingredients: MCT oil, broad-spectrum CBD oil (2500 mg cannabidiol from Swiss hemp)
• Contents per bottle: 10 ml, corresponding to approx. 270 drops
• THC content: 0.0% - lab tested and confirmed THC free

Instructions for use

Shake the bottle well before use. Apply a few drops to the desired skin area morning and evening for best results. For new users, it is recommended to start with a low dose to assess the skin's response. Store in a cool, dry place, protected from direct sunlight to preserve quality.

Quality control and test results

All our CBD products undergo strict quality controls. This CBD oil is laboratory tested in Switzerland to confirm cannabinoid content and microbiological safety, as well as to ensure the absence of heavy metals, pesticides and other contaminants. We work with a British partner who supplies biodegradable packaging, which supports our environmentally friendly approach and ensures a sustainable production chain.

Reservation

Only for adults over 18 years of age. Not recommended for pregnant or lactating women without medical approval. This product is intended for cosmetic use and not for oral administration. Uno Vita AS makes no medical claims about the product's effectiveness. We always recommend consulting a healthcare professional before use if you have medical conditions or are taking prescription medication.

Freedom of expression and right to information

Uno Vita reserves the right to share publicly available research and information on health and wellness technologies, natural substances, vitamins and the like in accordance with laws on freedom of expression. This includes:

• United Nations Universal Declaration of Human Rights (1948): Article 19
• The International Covenant on Civil and Political Rights (1966): Article 19
• Section 100 of the Norwegian Constitution
• America's First Amendment

Relevant references:

1. Huestis, M.A. (2007). Human Cannabinoid Pharmacokinetics.
2. Grotenhermen, F. (2003). Pharmacokinetics and pharmacodynamics of cannabinoids.
3. Mechoulam, R., & Parker, L.A. (2013). The endocannabinoid system and the brain.
4. Russo, E. B. (2011). Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
5. Pertwee, R.G. (2006). Cannabinoid pharmacology.
6. Pisanti, S., et al. (2017). Cannabidiol: State of the art and new challenges for therapeutic applications.
7. McPartland, J.M., et al. (2015). Cannabidiol modulation of the endocannabinoid system.
8. Zuardi, A.W. (2008). Cannabidiol: A drug with a wide spectrum of action.
9. Pamplona, ​​F.A., et al. (2018). The anti-inflammatory properties of cannabidiol.
10. Shannon, S., et al. (2019). Cannabidiol in anxiety and sleep.
11. Ashton, C.H. (2001). Effects of cannabis: A brief review.
12. Pertwee, R.G., et al. (2018). Cannabinoids in health and disease.